Canadian Cancer Trials Group Bulletins


Recent Publications

Forster MD, Saijo N, Seymour L, Calvert H. Performing phase I clinical trials of anticancer agents: Perspectives from within the European Union and Japan. Clin Cancer Res 16: 1737-44, 2010.

LoRusso PM, Boerner SA, Seymour L. An overview of the optimal planning, design, and conduct of phase I studies of new therapeutics. Clin Cancer Res 16: 1710-8, 2010.

Seymour L, Ivy SP, Sargent D, Spriggs D, Baker L, Rubinstein L, Ratain MJ, Le Blanc M, Stewart D, Crowley J, Groshen S, Humphrey JS, West P, Berry D. The design of phase II clinical trials testing cancer therapeutics: Consensus recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee. Clin Cancer Res 16: 1764-9, 2010.

Canadian Cancer Trials Group BR.10 -- A Phase III Prospective Randomized Study of Adjuvant Chemotherapy with Vinorelbine and Cisplatin in Completely Resected Non-Small Cell Lung Cancer with Companion Tumour Marker Evaluation

NSCLC Meta-Analyses Collaborative Group. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data (ONLINE). Lancet 2010.